ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 166 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.08 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $571,705,000 | +47.4% | 16,629 | +23.6% | 0.35% | +43.5% |
Q4 2016 | $387,927,000 | +40.9% | 13,451 | +55.4% | 0.25% | +46.4% |
Q3 2016 | $275,347,000 | -12.2% | 8,656 | -10.4% | 0.17% | -13.0% |
Q2 2016 | $313,434,000 | +56.8% | 9,656 | +35.0% | 0.19% | +70.8% |
Q1 2016 | $199,942,000 | +143.8% | 7,151 | +210.9% | 0.11% | +140.4% |
Q4 2015 | $81,995,000 | +7.8% | 2,300 | 0.0% | 0.05% | -2.1% |
Q3 2015 | $76,061,000 | -21.0% | 2,300 | 0.0% | 0.05% | -12.7% |
Q2 2015 | $96,324,000 | +195.6% | 2,300 | +130.0% | 0.06% | +205.6% |
Q1 2015 | $32,590,000 | +156.6% | 1,000 | +150.0% | 0.02% | +80.0% |
Q4 2014 | $12,700,000 | -61.0% | 400 | -60.0% | 0.01% | -44.4% |
Q1 2014 | $32,590,000 | – | 1,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |